Chemed Corp. Company Profile (NYSE:CHE)

About Chemed Corp. (NYSE:CHE)

Chemed Corp. logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:CHE
  • CUSIP: 16359R10
  • Web:
  • Market Cap: $3.04613 billion
  • Outstanding Shares: 15,991,000
Average Prices:
  • 50 Day Moving Avg: $193.25
  • 200 Day Moving Avg: $196.09
  • 52 Week Range: $132.92 - $216.01
  • Trailing P/E Ratio: 47.21
  • Foreward P/E Ratio: 21.82
  • P/E Growth: 2.36
Sales & Book Value:
  • Annual Revenue: $1.62 billion
  • Price / Sales: 1.88
  • Book Value: $28.33 per share
  • Price / Book: 6.73
  • Annual Dividend: $1.12
  • Dividend Yield: 0.6%
  • EBIDTA: $226.52 million
  • Net Margins: 4.16%
  • Return on Equity: 26.18%
  • Return on Assets: 14.62%
  • Debt-to-Equity Ratio: 0.25%
  • Current Ratio: 0.58%
  • Quick Ratio: 0.56%
  • Average Volume: 100,536 shs.
  • Beta: 1.14
  • Short Ratio: 14.63

Frequently Asked Questions for Chemed Corp. (NYSE:CHE)

What is Chemed Corp.'s stock symbol?

Chemed Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed Corp. pay dividends? What is the dividend yield for Chemed Corp.?

Chemed Corp. announced a quarterly dividend on Friday, August 4th. Investors of record on Monday, August 14th will be given a dividend of $0.28 per share on Friday, September 1st. This represents a $1.12 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date is Thursday, August 10th. This is an increase from Chemed Corp.'s previous quarterly dividend of $0.26. View Chemed Corp.'s Dividend History.

How will Chemed Corp.'s stock buyback program work?

Chemed Corp. declared that its Board of Directors has initiated a stock repurchase program on Monday, April 10th 2017, which allows the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 3.3% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its stock is undervalued.

How were Chemed Corp.'s earnings last quarter?

Chemed Corp. (NYSE:CHE) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.26. The business had revenue of $415.06 million for the quarter, compared to analysts' expectations of $407.56 million. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. Chemed Corp.'s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.80 earnings per share. View Chemed Corp.'s Earnings History.

When will Chemed Corp. make its next earnings announcement?

Chemed Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Chemed Corp..

What guidance has Chemed Corp. issued on next quarter's earnings?

Chemed Corp. issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $8.10-8.20 for the period, compared to the Thomson Reuters consensus estimate of $7.96.

Where is Chemed Corp.'s stock going? Where will Chemed Corp.'s stock price be in 2017?

2 equities research analysts have issued 12 month price targets for Chemed Corp.'s shares. Their forecasts range from $209.00 to $220.00. On average, they expect Chemed Corp.'s share price to reach $214.50 in the next year. View Analyst Ratings for Chemed Corp..

Who are some of Chemed Corp.'s key competitors?

Who are Chemed Corp.'s key executives?

Chemed Corp.'s management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board
  • Kevin J. McNamara, President, Chief Executive Officer, Director
  • David Patrick Williams, Chief Financial Officer, Executive Vice President
  • Spencer S. Lee, Executive Vice President
  • Nicholas Michael Westfall, Executive Vice President
  • Michael D. Witzeman, Principal Accounting Officer, Controller
  • Thomas Charles Hutton, Director
  • Joel F. Gemunder, Independent Director
  • Patrick P. Grace, Independent Director
  • Walter L. Krebs, Independent Director

Who owns Chemed Corp. stock?

Chemed Corp.'s stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.00%), Vanguard Group Inc. (11.45%), Neuberger Berman Group LLC (6.37%), Riverbridge Partners LLC (4.17%), FMR LLC (4.11%) and Acadian Asset Management LLC (3.60%). Company insiders that own Chemed Corp. stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed Corp..

Who sold Chemed Corp. stock? Who is selling Chemed Corp. stock?

Chemed Corp.'s stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Investec Asset Management LTD, Riverbridge Partners LLC, Neuberger Berman Group LLC, Gamco Investors INC. ET AL, BTIM Corp., BlackRock Inc. and Fiera Capital Corp. Company insiders that have sold Chemed Corp. stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed Corp..

Who bought Chemed Corp. stock? Who is buying Chemed Corp. stock?

Chemed Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Voya Investment Management LLC, Renaissance Technologies LLC, Vanguard Group Inc., AJO LP, Old Mutual Global Investors UK Ltd., JPMorgan Chase & Co., Copeland Capital Management LLC and American Century Companies Inc.. Company insiders that have bought Chemed Corp. stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed Corp..

How do I buy Chemed Corp. stock?

Shares of Chemed Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed Corp.'s stock price today?

One share of Chemed Corp. stock can currently be purchased for approximately $190.74.

MarketBeat Community Rating for Chemed Corp. (NYSE CHE)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  233
MarketBeat's community ratings are surveys of what our community members think about Chemed Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Chemed Corp. (NYSE:CHE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $214.50 (12.46% upside)

Analysts' Ratings History for Chemed Corp. (NYSE:CHE)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/1/2017Royal Bank Of CanadaReiterated RatingHold$209.00N/AView Rating Details
8/28/2017KeyCorpInitiated CoverageSector Weight -> Sector WeightLowView Rating Details
7/27/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$200.00 -> $220.00MediumView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 9/22/2015 forward)


Earnings History for Chemed Corp. (NYSE:CHE)
Earnings by Quarter for Chemed Corp. (NYSE:CHE)
Earnings History by Quarter for Chemed Corp. (NYSE CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$2.00N/AView Earnings Details
7/25/2017Q2 2017$1.89$2.15$407.56 million$415.06 millionViewN/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chemed Corp. (NYSE:CHE)
2017 EPS Consensus Estimate: $7.89
2018 EPS Consensus Estimate: $8.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20172$1.97$2.02$2.00
Q4 20172$2.23$2.24$2.24
Q1 20181$1.95$1.95$1.95
Q2 20181$2.09$2.09$2.09
Q3 20181$2.14$2.14$2.14
Q4 20181$2.43$2.43$2.43
(Data provided by Zacks Investment Research)


Current Dividend Information for Chemed Corp. (NYSE:CHE)
Most Recent Dividend:9/1/2017
Annual Dividend:$1.12
Dividend Yield:0.59%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:28.07% (Trailing 12 Months of Earnings)
18.12% (Based on This Year's Estimates)
12.81% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Chemed Corp. (NYSE:CHE)

Dividend History by Quarter for Chemed Corp. (NYSE CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed Corp. (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 96.96%
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)
Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2017Spencer S LeeInsiderSell1,000$197.46$197,460.00View SEC Filing  
7/28/2017Kevin J McnamaraInsiderSell15,000$201.16$3,017,400.00View SEC Filing  
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.00View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Chemed Corp. (NYSE:CHE)
Latest Headlines for Chemed Corp. (NYSE:CHE)
DateHeadline logoWhy Should Investors Add Amedisys (AMED) to Their Portfolio? - September 21 at 4:58 PM logoHere's Why You Should Add Chemed (CHE) to Your Portfolio - September 21 at 10:45 AM logoChemed Getting Closer To Key Technical Measure - September 18 at 3:41 PM logoChemed Corp. (CHE) Stock Rating Upgraded by Zacks Investment Research - September 18 at 10:16 AM logoChemed Corp. (CHE) Given Average Recommendation of "Hold" by Brokerages - September 14 at 2:40 AM logoCVS Health Gains on Pharmacy Services, Retail Remains a Drag - September 13 at 6:21 PM logoChemed Corp. (CHE) Downgraded by Zacks Investment Research - September 13 at 6:04 PM logoZacks Investment Research Lowers Chemed Corp. (CHE) to Hold - September 10 at 5:52 PM logo Analysts Anticipate Chemed Corp. (CHE) Will Announce Earnings of $2.00 Per Share - September 10 at 4:10 PM logoNuVasive Grows in Pediatric Deformity With New FDA Approval - September 8 at 5:33 PM logoChemed Rides on VITAS Recovery, Robust Roto-Rooter Sales - September 8 at 5:33 PM logoAbbott (ABT) Hits a 52-Week High: What's Driving the Stock? - September 7 at 5:16 PM logoRoyal Bank Of Canada Reaffirms Hold Rating for Chemed Corp. (CHE) - September 2 at 6:56 AM logoSpencer S. Lee Sells 1,000 Shares of Chemed Corp. (CHE) Stock - September 1 at 4:20 PM logoComparing Select Medical Holdings Corporation (SEM) and Chemed Corp. (CHE) - September 1 at 12:26 PM logoOmnova Solutions and Chemed are Zacks Aggressive Growth Rank Buys - August 31 at 5:02 PM logoBrokers Issue Forecasts for Chemed Corp.'s Q3 2017 Earnings (CHE) - August 31 at 8:28 AM logoHere's Why Chemed (CHE) is a Suitable Growth Pick for Now - August 29 at 3:08 AM logoKeyCorp Initiates Coverage on Chemed Corp. (CHE) - August 28 at 10:28 AM logoWhy Is Chemed (CHE) Down 7.8% Since the Last Earnings Report? - August 25 at 6:56 PM logoChemed (CHE) on Growth Track With VITAS & Roto-Rooter Arms - August 25 at 6:56 PM logoChemed Co. (CHE) Lifted to "Buy" at Zacks Investment Research - August 23 at 4:46 PM logoChemed Co. (CHE) Stock Rating Lowered by Zacks Investment Research - August 22 at 3:50 PM logoChemed Corp. (CHE) Receives Average Recommendation of "Hold" from Analysts - August 20 at 2:26 AM logoETFs with exposure to Chemed Corp. : August 18, 2017 - August 18 at 5:16 PM logoSee what the IHS Markit Score report has to say about Chemed Corp. - August 10 at 3:22 AM logoEx-Dividend Reminder: Chemed, CNA Financial and Carlyle Group - August 8 at 4:54 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 7, 2017 - August 7 at 5:35 PM logoChemed Corporation Increases Quarterly Dividend 7.7% - August 4 at 5:24 PM logoChemed Corp. (CHE) Plans Dividend of $0.28 - August 4 at 2:44 PM logoChemed Enters Oversold Territory (CHE) - August 3 at 6:39 PM featured highlights: Arkema, Nutrisystem, SYNNEX, Ituran Location and Control and Chemed - August 3 at 6:39 PM logoChemed Corp. (NYSE:CHE) Insider Sells $3,017,400.00 in Stock - July 31 at 4:26 PM logoChemed Corp. (NYSE:CHE) Given Hold Rating at Royal Bank Of Canada - July 31 at 1:38 PM logoChemed Corp. to Post Q3 2017 Earnings of $1.97 Per Share, Oppenheimer Holdings Forecasts (NYSE:CHE) - July 31 at 7:51 AM logoChemed Corp. Expected to Post Q4 2017 Earnings of $2.23 Per Share (NYSE:CHE) - July 28 at 4:09 PM logoChemed Corp. (CHE) Lifted to "Buy" at Zacks Investment Research - July 28 at 2:09 PM logoChemed Corp. (CHE) Price Target Increased to $220.00 by Analysts at Oppenheimer Holdings, Inc. - July 27 at 1:14 PM logoEdited Transcript of CHE earnings conference call or presentation 26-Jul-17 2:00pm GMT - July 27 at 3:40 AM logoChemed Corp. (CHE) Given Consensus Recommendation of "Hold" by Brokerages - July 26 at 11:59 PM logoChemed Corp. (CHE) Cut to C+ at TheStreet - July 26 at 9:52 PM logoInvestor Network: Chemed Corporation to Host Earnings Call - July 26 at 5:42 PM logoComparing American Renal Associates Holdings (ARA) & Chemed Corp. (NYSE:CHE) - July 26 at 8:28 AM logoChemed Corp. (CHE) Issues FY17 Earnings Guidance - July 25 at 10:32 PM logoChemed Increases Earnings Guidance - Quick Facts - July 25 at 10:07 PM logoBRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15 - July 25 at 10:07 PM logoChemed reports 2Q loss - July 25 at 10:07 PM logoChemed Corp. (CHE) Releases Earnings Results, Beats Expectations By $0.26 EPS - July 25 at 9:05 PM logoChemed Reports Second-Quarter 2017 Results - July 25 at 5:05 PM logoETFs with exposure to Chemed Corp. : July 24, 2017 - July 24 at 4:44 PM



Chemed Corp. (CHE) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by Staff